RECK overexpression decreases invasive potential in prostate cancer cells

Prostate

Volumn 72, Issue 9, 2012, Pages 948-954

  Rabien, Anja ^a   Ergün, Bettina ^a   Erbersdobler, Andreas ^b   Jung, Klaus ^a,c   Stephan, Carsten ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c Berlin Institute for Urologic Research   (Germany)

Author keywords

invasion; MMP; prostate carcinoma; reversion inducing cysteine rich protein with Kazal motifs

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; PROTEIN REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER PATIENT; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN FUNCTION; WESTERN BLOTTING; ZYMOGRAPHY;

CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 84857290115     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21498     Document Type: Article

References (35)

1. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M,. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998; 95 (22): 13221-13226.
2. Miki T, Takegami Y, Okawa K, Muraguchi T, Noda M, Takahashi C,. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem 2007; 282 (16): 12341-12352.
3. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M,. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001; 107 (6): 789-800.
4. Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EP, Omura A, Miki T, Takahashi R, Matsumoto N, Ludwig A, Noda M, Takahashi C,. RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci 2007; 10 (7): 838-845.
5. Mori T, Moriuchi R, Okazaki E, Yamada K, Katamine S,. Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region. Biochem Biophys Res Commun 2007; 355 (4): 937-943.
6. Hsu MC, Chang HC, Hung WC,. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem 2006; 281 (8): 4718-4725.
7. Hong KJ, Hsu MC, Hou MF, Hung WC,. The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling. FEBS Lett 2011; 585 (4): 591-595.
8. Oh J, Seo DW, Diaz T, Wei B, Ward Y, Ray JM, Morioka Y, Shi S, Kitayama H, Takahashi C, Noda M, Stetler-Stevenson WG,. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res 2004; 64 (24): 9062-9069.
9. Oh J, Diaz T, Wei B, Chang H, Noda M, Stetler-Stevenson WG,. TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118. Oncogene 2006; 25 (30): 4230-4234.
10. Liu LT, Chang HC, Chiang LC, Hung WC,. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells. Oncogene 2002; 21 (54): 8347-8350.
11. Jeon HW, Lee YM,. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther 2010; 9 (5): 1361-1370.
12. Liu LT, Chang HC, Chiang LC, Hung WC,. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 2003; 63 (12): 3069-3072.
13. Lee KJ, Lee KY, Lee YM,. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Biochim Biophys Acta 2010; 1803 (5): 608-616.
14. Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M,. Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 2010; 29 (18): 2638-2648.
15. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM,. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008; 28 (17): 5369-5380.
16. Hu SJ, Ren G, Liu JL, Zhao ZA, Yu YS, Su RW, Ma XH, Ni H, Lei W, Yang ZM,. MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem 2008; 283 (34): 23473-23484.
17. Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu W, Yang K, He X, Chen S,. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010; 53 (1): 98-107.
18. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H,. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88 (12): 1358-1366.
19. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L,. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 2011; DOI: 10.1007/s12032-010-9563-7.
20. Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K,. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur Urol 2007; 51 (5): 1259-1266.
21. Riddick AC, Shukla CJ, Pennington CJ, Bass R, Nuttall RK, Hogan A, Sethia KK, Ellis V, Collins AT, Maitland NJ, Ball RY, Edwards DR,. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 2005; 92 (12): 2171-2180.
22. Wittschieber D, Stenzinger A, Klauschen F, Stephan C, Jung K, Erbersdobler A, Rabien A,. Decreased RECK and increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness. Pathobiology 2011; 78 (3): 123-131.
23. Rodrigues J, Abramjuk C, Vasquez L, Gamboa N, Dominguez J, Nitzsche B, Hopfner M, Georgieva R, Baumler H, Stephan C, Jung K, Lein M, Rabien A,. New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer. Pharm Res 2011; 28 (4): 907-919.
24. Simizu S, Takagi S, Tamura Y, Osada H,. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res 2005; 65 (16): 7455-7461.
25. Bonkhoff H, Berges R,. From pathogenesis to prevention of castration resistant prostate cancer. Prostate 2010; 70 (1): 100-112.
26. Kitajima S, Miki T, Takegami Y, Kido Y, Noda M, Hara E, Shamma A, Takahashi C,. Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling. Oncogene 2011; 30 (6): 737-750.
27. Tian QS, Li DC,. Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro. Saudi Med J 2010; 31 (7): 752-758.
28. Silveira Correa TC, Massaro RR, Brohem CA, Taboga SR, Lamers ML, Santos MF, Maria-Engler SS,. RECK-mediated inhibition of glioma migration and invasion. J Cell Biochem 2010; 110 (1): 52-61.
29. Clark JC, Akiyama T, Thomas DM, Labrinidis A, Evdokiou A, Galloway SJ, Kim HS, Dass CR, Choong PF,. RECK in osteosarcoma: A novel role in tumour vasculature and inhibition of tumorigenesis in an orthotopic model. Cancer 2011; 117 (15): 3517-3528.
30. Meng N, Li Y, Zhang H, Sun XF,. RECK, a novel matrix metalloproteinase regulator. Histol Histopathol 2008; 23 (8): 1003-1010.
31. Takagi S, Simizu S, Osada H,. RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res 2009; 69 (4): 1502-1508.
32. Yoshida D, Nomura R, Teramoto A,. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J Neurooncol 2008; 89 (2): 141-150.
33. Recillas-Targa F,. Gene transfer and expression in mammalian cell lines and transgenic animals. Methods Mol Biol 2004; 267: 417-433.
34. Hatta M, Matsuzaki T, Morioka Y, Yoshida Y, Noda M,. Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts. Cell Signal 2009; 21 (12): 1885-1893.
35. Miki T, Shamma A, Kitajima S, Takegami Y, Noda M, Nakashima Y, Watanabe K, Takahashi C,. The beta1-integrin-dependent function of RECK in physiologic and tumor angiogenesis. Mol Cancer Res 2010; 8 (5): 665-676.